Completed PHASE3 INTERVENTIONAL 2-arm NCT00255372

To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.

Polyethylene Glycol Laxative (Macrogol 4000;Forlax®) for Treatment of Chronic Constipation in Children : A Phase III, Bicentric, Randomized, Double-blind, Lactulose Controlled Study.

Sponsor: Ipsen

Conditions Chronic Constipation

Interventions Lactulose active and Lactulose placebo PEG 4000 (Forlax®)

Updated 8 times since 2017 Last updated: Apr 23, 2020 Started: Apr 30, 2005 Primary completion: May 20, 2008 Completion: May 20, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Chronic Constipation and is currently completed. Ipsen leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
May 2020 — Jan 2021 [monthly]

Completed PHASE3
Dec 2019 — May 2020 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Feb 2019 — Dec 2019 [monthly]

Completed PHASE3
Jun 2018 — Feb 2019 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ipsen

Data source: Ipsen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand
• Nakhon Ratchasima, Thailand